{"component": "definition", "props": {"groups": [{"snippet": "means [***] and [***].", "samples": [{"hash": "kD6oAnNRo5Z", "uri": "/contracts/kD6oAnNRo5Z#additional-territories", "label": "Distribution and Licensing Agreement (CareDx, Inc.)", "score": 25.4791238877, "published": true}, {"hash": "22gU0BygB3u", "uri": "/contracts/22gU0BygB3u#additional-territories", "label": "Distribution and Licensing Agreement (CareDx, Inc.)", "score": 25.4188911704, "published": true}, {"hash": "6Mi2Z2YM6Hd", "uri": "/contracts/6Mi2Z2YM6Hd#additional-territories", "label": "Distribution and Licensing Agreement (CareDx, Inc.)", "score": 25.3312799452, "published": true}], "size": 4, "snippet_links": [], "hash": "14b85dfc13077eea3a406261d313f031", "id": 1}, {"snippet": "means any additional territories outside the Territory but excluding the United Kingdom and the Republic of Ireland in which Oncogenerix may undertake the Activities as agreed in writing between the parties in accordance with Sections 3.l(b).", "samples": [{"hash": "7jbMGMTvDcd", "uri": "/contracts/7jbMGMTvDcd#additional-territories", "label": "Exclusive Distribution Agreement", "score": 31.340862423, "published": true}, {"hash": "jz9GBiWk9ns", "uri": "/contracts/jz9GBiWk9ns#additional-territories", "label": "Exclusive Distribution Agreement (DARA BioSciences, Inc.)", "score": 23.2559890486, "published": true}, {"hash": "hzSTgkCkOJS", "uri": "/contracts/hzSTgkCkOJS#additional-territories", "label": "Exclusive Distribution Agreement (DARA BioSciences, Inc.)", "score": 23.1957563313, "published": true}], "size": 3, "snippet_links": [{"key": "outside-the-territory", "type": "clause", "offset": [33, 54]}, {"key": "but-excluding", "type": "clause", "offset": [55, 68]}, {"key": "the-united-kingdom", "type": "clause", "offset": [69, 87]}, {"key": "republic-of-ireland", "type": "clause", "offset": [96, 115]}, {"key": "the-activities", "type": "clause", "offset": [151, 165]}, {"key": "as-agreed", "type": "clause", "offset": [166, 175]}, {"key": "in-writing", "type": "definition", "offset": [176, 186]}, {"key": "between-the-parties", "type": "clause", "offset": [187, 206]}, {"key": "in-accordance-with", "type": "definition", "offset": [207, 225]}], "hash": "0cd8df5c256450acf05871cd52498289", "id": 2}, {"snippet": "means the Commonwealth of Australia and the Republic of Singapore.", "samples": [{"hash": "79xRbCcYqPk", "uri": "/contracts/79xRbCcYqPk#additional-territories", "label": "Exclusive Licensing and Distribution Agreement (Fluoropharma Medical, Inc.)", "score": 27.4366872005, "published": true}, {"hash": "1TdVZN9muM2", "uri": "/contracts/1TdVZN9muM2#additional-territories", "label": "Exclusive Licensing and Distribution Agreement (Fluoropharma Medical, Inc.)", "score": 27.4366872005, "published": true}], "size": 2, "snippet_links": [{"key": "commonwealth-of-australia", "type": "definition", "offset": [10, 35]}], "hash": "0aae9fcd0729f6bcf19f9d9aaaf267eb", "id": 3}, {"snippet": "means the European Union (as defined below), Mexico and Australia.", "samples": [{"hash": "c0m5oKrUAuF", "uri": "/contracts/c0m5oKrUAuF#additional-territories", "label": "Manufacturing and Sales License Agreement (Valens Company, Inc.)", "score": 32.8767967146, "published": true}, {"hash": "7kZfKYJSpqM", "uri": "/contracts/7kZfKYJSpqM#additional-territories", "label": "Manufacturing Agreement (Valens Company, Inc.)", "score": 32.8767967146, "published": true}], "size": 2, "snippet_links": [{"key": "the-european-union", "type": "clause", "offset": [6, 24]}], "hash": "438a245e64c9600202fb27009a8dff8d", "id": 4}, {"snippet": "means any other country or jurisdiction. RDT may add to this Schedule \"D\" from time to time after the Effective Date pursuant to Article 7 of the Agreement; State or Country", "samples": [{"hash": "Q5aw13l6h", "uri": "/contracts/Q5aw13l6h#additional-territories", "label": "Managed Strip Services Agreement (Chemesis International Inc.)", "score": 31.379192334, "published": true}, {"hash": "ghDPD1PR6JV", "uri": "/contracts/ghDPD1PR6JV#additional-territories", "label": "Managed Strip Services Agreement", "score": 26.2511978097, "published": true}], "size": 2, "snippet_links": [{"key": "add-to", "type": "clause", "offset": [49, 55]}, {"key": "from-time-to-time", "type": "clause", "offset": [74, 91]}, {"key": "after-the-effective-date", "type": "clause", "offset": [92, 116]}, {"key": "pursuant-to-article-7", "type": "clause", "offset": [117, 138]}, {"key": "the-agreement", "type": "clause", "offset": [142, 155]}], "hash": "c30d6a69aecf21d78d5a58c1bade1e82", "id": 5}, {"snippet": "means all territories other than Current Territories, excluding the People\u2019s Republic of China", "samples": [{"hash": "hmOQ47V5JUg", "uri": "/contracts/hmOQ47V5JUg#additional-territories", "label": "Memorandum of Understanding (Wize Pharma, Inc.)", "score": 26.424366872, "published": true}, {"hash": "7LdNhm4VucW", "uri": "/contracts/7LdNhm4VucW#additional-territories", "label": "Memorandum of Understanding (Wize Pharma, Inc.)", "score": 26.2381930185, "published": true}], "size": 2, "snippet_links": [{"key": "the-people", "type": "definition", "offset": [64, 74]}, {"key": "republic-of-china", "type": "clause", "offset": [77, 94]}], "hash": "94bf9ccfc3ba4a29d1efd67c20ed50b0", "id": 6}, {"snippet": "Any territories for which Kamada shall appoint Kedrion as exclusive distributor of the Product, in addition to the Territory. shall be replaced in its entirety by the following:", "samples": [{"hash": "b7PeMReuwcE", "uri": "/contracts/b7PeMReuwcE#additional-territories", "label": "Supply and Distribution Agreement (Kamada LTD)", "score": 36.1731690623, "published": true}], "size": 2, "snippet_links": [{"key": "exclusive-distributor", "type": "definition", "offset": [58, 79]}, {"key": "the-product", "type": "clause", "offset": [83, 94]}, {"key": "the-territory", "type": "clause", "offset": [111, 124]}], "hash": "e8605d3f728006634c14c06506bb8346", "id": 7}, {"snippet": "has the meaning ascribed to it in Schedule \"D\";", "samples": [{"hash": "Q5aw13l6h", "uri": "/contracts/Q5aw13l6h#additional-territories", "label": "Managed Strip Services Agreement (Chemesis International Inc.)", "score": 31.379192334, "published": true}], "size": 2, "snippet_links": [], "hash": "09b3b57a613092abbdcd4e5b40102ad8", "id": 8}, {"snippet": "means any new additional territories incorporated into the Agreement according to the provisions set forth in Schedule 3A) Affiliate means persons or entities that directly or indirectly through one or more intermediaries control or are controlled by or are under common control with a specified party. The term control (including the terms controlled by and under common control with) means the possession directly or indirectly of the power to direct of cause the direction of the management and policies of an entity whether through the ownership of voting securities by contract or otherwise. Adverse events means any undesirable event (from any source including consumers) reported to Silmarc Pharma, or of which Silmarc Pharma becomes aware associated with the use of the Products in humans. This includes events experienced in the course of use. DHPI accepts no liability beyond what insurance is or may be in accordance with the product liability, as per attached copy of the insurance.", "samples": [{"hash": "a9Gmyi9vs1U", "uri": "/contracts/a9Gmyi9vs1U#additional-territories", "label": "Distribution Agreement (Desert Health Products Inc)", "score": 18.0, "published": true}], "size": 1, "snippet_links": [{"key": "the-agreement", "type": "clause", "offset": [55, 68]}, {"key": "according-to", "type": "definition", "offset": [69, 81]}, {"key": "the-provisions", "type": "clause", "offset": [82, 96]}, {"key": "schedule-3a", "type": "clause", "offset": [110, 121]}, {"key": "directly-or-indirectly", "type": "clause", "offset": [164, 186]}, {"key": "under-common-control", "type": "definition", "offset": [258, 278]}, {"key": "specified-party", "type": "definition", "offset": [286, 301]}, {"key": "the-terms", "type": "definition", "offset": [331, 340]}, {"key": "the-management", "type": "definition", "offset": [479, 493]}, {"key": "policies-of", "type": "definition", "offset": [498, 509]}, {"key": "securities-by", "type": "definition", "offset": [560, 573]}, {"key": "adverse-events", "type": "definition", "offset": [597, 611]}, {"key": "associated-with", "type": "definition", "offset": [747, 762]}, {"key": "use-of-the-products", "type": "clause", "offset": [767, 786]}, {"key": "in-the-course-of", "type": "definition", "offset": [831, 847]}, {"key": "no-liability", "type": "definition", "offset": [866, 878]}, {"key": "in-accordance-with", "type": "definition", "offset": [914, 932]}, {"key": "product-liability", "type": "definition", "offset": [937, 954]}, {"key": "the-insurance", "type": "clause", "offset": [980, 993]}], "hash": "6fcf69acf1a672ba6a9449eabce8ca23", "id": 9}, {"snippet": "means Italy, Greece, Cyprus, Turkey, Romania, Sweden, Denmark, Norway and/or Finland.", "samples": [{"hash": "hoYyIftKZ60", "uri": "/contracts/hoYyIftKZ60#additional-territories", "label": "Data Transfer & Patent License Agreement (Avanir Pharmaceuticals)", "score": 21.0, "published": true}], "size": 1, "snippet_links": [], "hash": "dc8450c2525828aaa4add7772a7cff87", "id": 10}], "next_curs": "CmMSXWoVc35sYXdpbnNpZGVyY29udHJhY3Rzcj8LEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIfYWRkaXRpb25hbC10ZXJyaXRvcmllcyMwMDAwMDAwYQyiAQJlbhgAIAA=", "definition": {"title": "Additional Territories", "snippet": "means [***] and [***].", "size": 22, "id": "additional-territories", "examples": ["XDx shall not, and shall ensure that its Affiliates shall not, conduct any negotiations with any third party with respect to such licence or launch of the Products in the <strong>Additional Territories</strong> for a period of four (4) months following the service of such notice.", "If the Parties have not entered into a definitive agreement in relation to such Territories, <strong>Additional Territories</strong> and Indications within the [***] period, ERYTECH Pharma shall be entitled to enter into a license or other distribution arrangement in relation to such Territories, <strong>Additional Territories</strong> and Indications with a Third Party provided that the [***].", "If medac notifies ERYTECH Pharma that it wishes to enter into discussions in relation to a license or other distribution arrangement for such Territories, <strong>Additional Territories</strong> and indications the Parties shall negotiate exclusively in relation to the same for a period of [***] from the response of medac.", "Rosemont will consider in good faith such a request but shall not be obliged to agree to the inclusion of any <strong>Additional Territories</strong>.", "VCP shall pay Oji royalties on the Net Sales Price of Oji Technology Thermal Paper Products sold or distributed in the <strong>Additional Territories</strong> as specified in Sections 3.01(c)(i) through (xiii), unless otherwise stated in the Additional Territory Written Consent, in which case the royalties payable with respect to Oji Technology Thermal Paper Products shall be on the terms set forth in the Additional Territory Written Consent.", "Any agreement between the Parties regarding <strong>Additional Territories</strong> shall be made in accordance with Section 16.5.", "By notifying Babelcube that Rights Holder wishes to include <strong>Additional Territories</strong>, Rights Holder makes all representations and warranties in Section 3 of this Agreement with respect to the <strong>Additional Territories</strong>.", "With respect to any <strong>Additional Territories</strong>, any necessary trademark applications and registrations shall be deemed to be Licensed Trademarks.", "Oncogenerix may make a written request to Rosemont to extend the Activities relating to the Licensed Product into <strong>Additional Territories</strong>.", "If Knight exercises such right, then the said <strong>Additional Territories</strong> and the Licensed Product(s) referred to in such Territory shall be deemed to be part of the \u201cTerritory\u201d for all purposes of this Agreement."], "related": [["territories", "Territories", "Territories"], ["restricted-territories", "Restricted Territories", "Restricted Territories"], ["geographic-territory", "Geographic Territory", "Geographic Territory"], ["service-territory", "Service Territory", "Service Territory"], ["territory", "Territory", "Territory"]], "related_snippets": [], "updated": "2025-07-06T21:58:36+00:00"}, "json": true, "cursor": ""}}